Skip to content
Angion Biomedica Corp

Angion Biomedica Corp

ANGION IS A LATE-STAGE CLINICAL COMPANY DEVELOPING SMALL MOLECULES TARGETING ACUTE ORGAN INJURY AND CHRONIC FIBROSIS

  • about
    • executive management
    • scientific advisory board
    • board of directors
  • our science
    • organ fibrosis
    • HGF/c-met pathway
  • pipeline
    • ANG-3070
    • ANG-3777
    • ROCK2 Inhibitor
    • CYP11B2 Inhibitor
  • Investors
    • stock information
      • stock quote & chart
      • historic price lookup
    • analyst coverage
    • press releases
    • events & presentations
    • sec filings
    • governance
    • investor resources
      • investor contact
      • investor FAQs
      • email alerts
  • publications
  • careers
  • contact

Author: angion2

May 7, 2020February 5, 2021

Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation

Posted in angion publications
January 8, 2020February 5, 2021

The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States (Incerti, et al)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Delayed Graft Function: The AKI of Kidney Transplantation (Mannon)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Improving the Supply and Quality of Deceased-Donor Organs for Transplantation (Tullus & Rabb)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Heart Disease and Stroke Statistics 2018 Update: A Report From the American Heart Association (Benjamin, et al)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Cardiac surgery-associated acute kidney injury: Risk factors, pathophysiology and treatment (Wang & Bellomo)

Posted in RSL-AKI
January 8, 2020February 5, 2021

The Economic Consequences of Acute Kidney Injury (Silver & Chertow)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Acute Kidney Injury in the Era of the AKI E-Alert (Holmes, et al)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Acute kidney injury following cardiac surgery: Current understanding and future directions (O’Neal, et al)

Posted in RSL-AKI
January 8, 2020February 5, 2021

Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation (Wu, et al)

Posted in RSL-AKI

Posts navigation

Older posts

CATEGORIES

  • RSL-HGF
  • RSL-ALI
  • Fibrosis
  • ROCKi
  • angion publications
  • RSL-AKI
  • events

CORPORATE ADDRESS

51 Charles Lindbergh Boulevard
Uniondale, NY 11553

Navigation

  • home
  • about
  • our science
  • pipeline
  • investors
  • publications
  • careers
  • contact

© 2022 Angion. All Rights Reserved.
Legal and Privacy Policy

NEW YORK | BOSTON | AUSTRALIA